Mentor Capital Again Invests in G FarmaLabs Success

SAN DIEGO--(BUSINESS WIRE)--Mentor Capital, Inc. (OTCQB: MNTR) is happy to announce that it has
extended its funding to G FarmaLabs by an extra 20% with an additional
loan on top of last month’s million dollar investment in this global
cannabis leader founded under the vision, energy and genius of Ata
Gonzalez. As his new advertisements indicate, Ata chooses to utilize the
additional liquidity from this month’s two hundred thousand dollar
investment to help launch G Farma’s program for the financing and
support of new commercially licensed cultivators.

These early investments are a microcosm of the larger common vision of
Mentor and G Farma. Ata Gonzalez explains, “There is a huge disconnect
between cannabis operators and outside businessmen with financial
resources. The businessman can build a $20 million facility, but fail to
profit in the unique marijuana market. The experienced operator could
build a $120 million brand if he could link to responsible financing.
Yet, they will both fail to find great success unless a bridge can be
built to connect both worlds. Mentor and G Farma provide that
money-to-market bridge.”

Mentor Capital CEO, Chet Billingsley, concurs, “Investors and
institutions that want to participate in the 2017 GreenRush and 34%
projected annual medical marijuana and adult cannabis market growth can
be comfortable with the public structures of Mentor Capital. In turn, we
look to work through and with G Farma to receive, channel and in some
cases approve major cannabis recipients of the investor funds we send
across the bridge into G Farma or to other major operators they endorse.
Our particular core focus is larger cannabis companies that, like G
Farma, could benefit from sophisticated mentoring toward an IPO in
addition to our significant cash investment.”

Billingsley concludes, “Over the years, in other sectors, Mentor Capital
has focused on raising and then carefully deploying investors’ capital
by teaming with great performers like Ata Gonzalez. Starting in 2000
with a company value of just $260,000 Mentor has grown to a market
capitalization of $36 million. Most Mentor funds have been recently
raised for the cannabis sector and overall, direct investors are
reflecting a 200% gain. But, we are humbled by Ata who started with much
less in 2009, slept next to his product to keep it safe, and by October
2016 was discussing events involving 2.5 tons of marijuana. I just have
to think that our bridging millions in capital to these tons of
marijuana, working with a great guy I have been discussing this with
since 2013, is a winning opportunity for us all.”

About Mentor Capital: The Company seeks to come alongside and
assist private medical marijuana and cannabis companies and their
founders in meeting their liquidity and financial objectives, to add
protection for investors and to help incubate private cannabis
companies. Additional important information for investors is presented
at: www.MentorCapital.com.

This press release is neither an offer to sell, nor a solicitation of
offers to purchase, securities.

Forward Looking Statements: This press release contains
forward-looking statements within the meaning of the federal securities
laws, including statements concerning financial projections, financing
activities, corporate combinations, product development activities and
sales and licensing activities.Such forward-looking statements
are not guarantees of future results or performance, are sometimes
identified by words of condition such as “should,” “could,” “expects,”
“may,” “intends,” “seeks,” “looks,” “moves,” or “plans” and are subject
to a number of risks and uncertainties, known and unknown, that could
cause actual results to differ materially from those intended or
anticipated. Such risks include, without limitation: nonperformance of
investments, partner and portfolio difficulties, potential delays in
marketing and sales, problems securing the necessary financing to
continue operations, problems involving continued illegality of cannabis
products, potential of competitive products, services, and technologies,
difficulties experienced in product development, in recruiting
knowledgeable personnel, in collecting judgments and in protecting
intellectual property. Further information concerning these and other
risks is included in the Company’s Form 10-K and 10-Q filings which,
along with other very important information about the Company, can be
found here: